Judith (Hudi) Licht

Affiliations: 
National Institute of Mental Health, Bethesda, MD, United States 
Google:
"Judith Licht"
Mean distance: (not calculated yet)
 

Parents

Sign in to add mentor
Shruti Japee research assistant 2018-2018 NIMH
 (summer student)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Zee BM, Poels KE, Yao CH, et al. (2021) Combined epigenetic and metabolic treatments overcome differentiation blockade in acute myeloid leukemia. Iscience. 24: 102651
Hogg SJ, Motorna O, Cluse LA, et al. (2021) Targeting histone acetylation dynamics and oncogenic transcription by catalytic P300/CBP inhibition. Molecular Cell. 81: 2183-2200.e13
Licht JD, Bennett RL. (2021) Leveraging epigenetics to enhance the efficacy of immunotherapy. Clinical Epigenetics. 13: 115
Prado G, Kaestner CL, Licht JD, et al. (2021) Targeting epigenetic mechanisms to overcome venetoclax resistance. Biochimica Et Biophysica Acta. Molecular Cell Research. 1868: 119047
Jooß K, Schachner LF, Watson R, et al. (2021) Separation and Characterization of Endogenous Nucleosomes by Native Capillary Zone Electrophoresis-Top-Down Mass Spectrometry. Analytical Chemistry
Shirasaki R, Matthews GM, Gandolfi S, et al. (2021) Functional Genomics Identify Distinct and Overlapping Genes Mediating Resistance to Different Classes of Heterobifunctional Degraders of Oncoproteins. Cell Reports. 34: 108532
Yusufova N, Kloetgen A, Teater M, et al. (2020) Histone H1 loss drives lymphoma by disrupting 3D chromatin architecture. Nature
Licht JD. (2020) Histone H3 G34 Tail Mutations in Cancer: Actions in and to Alter Chromatin and Gene Expression. Cancer Discovery. 10: 1794-1796
Ordonez R, Kulis M, Russinol N, et al. (2020) Chromatin activation as a unifying principle underlying pathogenic mechanisms in multiple myeloma. Genome Research
Longo J, Smirnov P, Li Z, et al. (2020) The mevalonate pathway is an actionable vulnerability of t(4;14)-positive multiple myeloma. Leukemia
See more...